ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,440.58
0.08%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,348.625
-0.49%
Brent Oil
82.765
0.46%
Bitcoin
62,416.64
1.58%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Manhattan Pharmaceuticals (MHA)

  7. Manhattan Pharmaceuticals (MHA) News

Manhattan Pharmaceuticals (MHA)

Manhattan Pharmaceuticals
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:MHA
DateTimeSourceHeadlineSymbolCompany
19/03/200816:35Edgar (US Regulatory)Manhattan Pharmaceuticals Inc-Amended Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/re.. (25/A)AMEX:MHAManhattan Pharmaceuticals
10/03/200818:14Edgar (US Regulatory)Manhattan Pharmaceuticals Inc-Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/retired sec. (25)AMEX:MHAManhattan Pharmaceuticals
05/03/200821:19Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)AMEX:MHAManhattan Pharmaceuticals
28/02/200819:43Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
13/02/200822:12Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)AMEX:MHAManhattan Pharmaceuticals
06/02/200822:00Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
03/01/200819:56Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
10/12/200712:07Business WireAMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance with Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
14/11/200715:00Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:MHAManhattan Pharmaceuticals
03/10/200721:02Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
03/10/200721:02Edgar (US Regulatory)Manhattan Pharmaceuticals Inc - Current report filing (8-K)AMEX:MHAManhattan Pharmaceuticals
21/09/200719:35Edgar (US Regulatory)Manhattan Pharmaceuticals Inc (Other) (8-K)AMEX:MHAManhattan Pharmaceuticals
10/07/200712:00PR Newswire (US)Manhattan Pharmaceuticals Provides Update on Clinical PipelineAMEX:MHAManhattan Pharmaceuticals
09/07/200721:30PR Newswire (US)Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estroneAMEX:MHAManhattan Pharmaceuticals
27/06/200713:59PR Newswire (US)Manhattan Pharmaceuticals Acquires Hedrin(TM) for the Treatment of Head LiceAMEX:MHAManhattan Pharmaceuticals
10/05/200714:29PR Newswire (US)Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for ObesiAMEX:MHAManhattan Pharmaceuticals
04/04/200714:29PR Newswire (US)Manhattan Pharmaceuticals Announces License Agreement and Expanded PipelineAMEX:MHAManhattan Pharmaceuticals
02/04/200714:29PR Newswire (US)Manhattan Pharmaceuticals Completes $8.6 Million Private PlacementAMEX:MHAManhattan Pharmaceuticals
27/03/200714:29PR Newswire (US)AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance With Continued Listing StandardsAMEX:MHAManhattan Pharmaceuticals
21/02/200713:29PR Newswire (US)Manhattan Pharmaceuticals Completes Enrollment in Phase 2a Study of Oral Oleoyl-estrone for ObesityAMEX:MHAManhattan Pharmaceuticals
08/11/200613:29PR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
08/11/200613:29PR Newswire (US)Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to USAMEX:MHAManhattan Pharmaceuticals
12/10/200614:29PR Newswire (US)Manhattan Pharmaceuticals Expanding Oral Oleoyl-estrone Clinical Program to Include Morbidly ObeseAMEX:MHAManhattan Pharmaceuticals
29/06/200616:29PR Newswire (US)Manhattan Pharmaceuticals Doses First Patient Group In Phase IIa Trial For OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
16/05/200614:02PR Newswire (US)Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug CandidateAMEX:MHAManhattan Pharmaceuticals
28/12/200516:25PR Newswire (US)Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa TrialAMEX:MHAManhattan Pharmaceuticals
07/10/200518:35PR Newswire (US)American Stock Exchange Lists Common Stock of Manhattan Pharmaceutical Inc.AMEX:MHA
 Showing the most relevant articles for your search:AMEX:MHA

Your Recent History

LSE
PET
Petrel Resources
LSE
SFOR
S4 Capital
LSE
GKP
Gulf Keystone Petroleum
LSE
PANR
Pantheon Resources
LSE
RR.
Rolls-royce
LSE
TXP
Touchstone Exploration
LSE
KEFI
Kefi Gold And Copper
LSE
ZOO
Zoo Digital
LSE
BBSN
Brave Bison
LSE
ASC
Asos
LSE
SYME
Supply@me Capital
LSE
HE1
Helium One Global
LSE
TERN
Tern
LSE
OPTI
Optibiotix Health
LSE
GOLD
LSE
AYM
Anglesey Mining
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved